Centre Hospitalier Intercommunal Creteil — Clinical Trial Site

167 Registered trials

85 Currently recruiting

Organisation

Centre Hospitalier Intercommunal Creteil

Location

Creteil, France

Identifier

ORG-100042860

Address

40 Avenue De Verdun, 94010, France

Departments

#2303:Service de Pédiatrie
2304:Service de Pneumologie
250005: Service Ophtalmologie
3205: Ophtalmology
94000
94010
CHI Créteil - Pneumologie
Consultation pediatrique
Creteil CHIC (enfants)
Département de Pneumologie
DERMATOLOGIE
Dermatology
Dermatology department
FRA009: Centre de Coordination en Cancérologie
gastroenterology
gynecology
hépatogastroentérologie
Hepatogastroenterology
INFECTIOLOGY
Intensive care
Internal medecine
Internal Medicine
Maladies infectieuses et Tropicales
Maternité
Médecine interne
Medical onclogy
Medical oncology
N/A
Néonatologie
Neonatology
Obstetric gynecology
Obstetrics
ONCOLOGIE
ONCOLOGIE MEDICALE
Oncologie-Radiothérapie
oncology
Oncology-Radiotherapy
Ophtalmologie
Ophtalmology
Ophthalmology
Ophthalmology Department
Orthopédie
Paediatrics
Pédiatrie
Pédiatrie Générale
PMA
Pneumologie
Pneumologie / UFR Sante Medecine
Pneumologie Batiment U
Pneumologie Oncologie thoracique
Pneumology
Pneumology and Thoracic Oncology
Pneumology department
Public health and Social Medicine
Pulmonology
Radiothérapie
Radiotherapy
Radiotherapy -Oncology
Réanimation médicale
Service d'Hepato-Gastro-Enterologie
Service d'Hépatologie
Service d'Ophtalomologie
Service d’ophtalmologie
Service de gastroentérologie et hépatologie
Service de gynécologie obstétrique, - unité de médecine de la reproduction
Service de Médecine Interne
Service de Pediatrie
Service de pédiatrie - Hôpital de jour
Service de Pneumologie
Service de pneumologie; Service de pédiatrie
Service Hepato-gastroenterologie
Service Ophtalmologie
Service Pédiatrie - Reference centres for SCD
Service Pneumologie
Service pneumology
Urgences pédiatriques

Clinical trials at this site (167)

Search interface

Phase 3 Study Comparing Zimberelimab with Domvanalimab to Pembrolizumab in Advanced Non-Small Cell Lung Cancer Ended

2022-503071-28-00 Squamous Non-small cell Lung Cancer 5 2023-08-31
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 2) Ended

2023-504238-23-00 Hepatitis B, Chronic 5 2023-01-17
An Open-Label Extension Study for Patients who Previously Completed Study ISEE2008 (GATHER2) Ended

2024-515185-13-00 geographic atrophy 5 2022-12-21
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed S… Ended

2024-513559-34-00 Small Cell Lung Cancer (SCLC) 5 2022-07-19
Randomized multicenter double-blind controlled trial comparing anakinra to prednisone for gout flare in patients with chronic kidney disease… Ended

2024-514347-28-00 Men and women over 18 years of age with renal failure r 5 2022-06-02
Evaluation of MEpolizumab-based regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Eosinophilic … Ended

2024-513653-75-00 Eosinophilic granulomatosis with polyangiitis (EGPA), f 5 2022-05-30
A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Ended

2023-508571-37-00 Geographic atrophy (GA) secondary to Age-related Macula 4 2022-04-29
A study to evaluate long-term safety of nintedanib in children and adolescents with interstitial lung disease (InPedILD®-ON) Ended

2024-515743-27-00 Childhood Interstitial Lung Disease 5 2022-04-04
Study comparing the standard administration of immunotherapy (IO) versus the same agent administered each three months in patients with loca… Ended

2024-513707-14-00 Only patients with oncologic locally advanced or metast 5 2022-01-14
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects with Geographic Atrophy Secondary to … Ended

2024-512945-18-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2021-11-30
A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti-TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab… Ended

2023-507317-10-00 Locally advanced, unresectable, or metastatic non small 5 2021-05-10
A study to evaluate the effects of ALIS based treatment in patients newly diagnosed with nontuberculous mycobacterial lung infection caused … Ended

2023-505273-33-00 "Adult Subjects with Newly Diagnosed Nontuberculous Myc 5 2021-02-15
Randomized trial evaluating adapted chemotherapy in patients with squamous carcinoma Ended

2024-512456-38-00 locally advanced squamous cell carcinoma 4 2021-02-04
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants wit… Ended

2023-508443-40-00 Lung Cancer, Non-Small Cell 5 2020-12-18
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2) Ended

2023-506724-85-00 Migraine 5 2020-11-19
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1) Ended

2023-506253-38-00 Migraine 5 2020-11-09
A multicentre phase II, open-label, non-randomized study evaluating Platinum-Pemetrexed-Atezolizumab ( Bevacizumab) for patients with stage … Ended

2024-516201-23-00 Lung Cancer, NSCLC 4 2019-08-26
Comparative multicenter randomized study of aflibercept versus placebo in macular telangiectasia type 1 Ended

2024-511885-35-00 macular telangiectasia type 1 5 2019-07-03
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn's Disease Ended

2023-510426-33-00 Moderately to Severely Active Crohn's Disease 5 2018-09-27
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Can… Ended

2024-517856-36-00 Completely resected primary stage IB (≥ 4cm), II and II 5 2015-03-09
A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edem… Ended

2023-507207-66-00 Diabetic Macular Edema (DME) 5
A clinical study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with metastatic nons… Ended

2024-515393-27-00 Nonsquamous non-small cell lung cancer 4
Randomized Phase II Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab in Locally Advanc… Ended

2024-515533-15-00 Locally advanced cervical cancer 4